U.S. Beverage Stock News

NasdaqGS:APEI
NasdaqGS:APEIConsumer Services

American Public Education (APEI) Margin Expansion Reinforces Bullish Earnings Narrative In Q1 2026

American Public Education (APEI) opened 2026 with Q1 revenue of US$174.7 million and basic EPS of US$0.97, with net income excluding extra items at US$17.7 million, setting the tone for the year. The company has seen quarterly revenue move from US$164.6 million and EPS of US$0.42 in Q1 2025 to US$174.7 million and EPS of US$0.97 in Q1 2026. Trailing twelve month EPS has reached US$1.96, giving investors a clearer read on earnings momentum and margin resilience. With net margin over the last...
NYSE:MCO
NYSE:MCOCapital Markets

A Look At Moody's (MCO) Valuation As Macro Credit Signals Draw Fresh Investor Interest

Moody's (MCO) is drawing fresh attention after CFO Noemie Clemence Heuland was scheduled to present at Barclays' Americas Select Conference in London, as investors weigh new macro commentary against recent AI-driven trading signals. See our latest analysis for Moody's. At a share price of US$451.75, Moody's has seen a 5.69% 1 month share price return and 9.59% 3 month share price return, while the year to date share price is down 9.47% and the 1 year total shareholder return is down 6.06%...
NYSE:STE
NYSE:STEMedical Equipment

Steris (STE) Margin Improvement Reinforces Bullish Narratives Despite Premium P/E Multiple

STERIS (STE) has put fresh numbers on the table for FY 2026, with Q4 revenue of US$1.6 billion and basic EPS of US$2.25, framed against trailing 12 month revenue of US$5.9 billion and EPS of US$7.97, alongside earnings growth of 28.2% over the past year and a five year annualized earnings growth rate of 21.6%. Over recent periods, quarterly revenue has ranged from US$1.4 billion to US$1.6 billion while basic EPS has moved between US$1.80 and US$2.25, and investors now have a clearer view of...
NYSE:ESTC
NYSE:ESTCSoftware

Assessing Elastic (ESTC) Valuation After A Year Of Share Price Weakness

Elastic stock in focus Elastic (ESTC) has drawn investor attention after recent share price swings, with the stock closing at US$50.09 and showing mixed performance over the past month and past 3 months. See our latest analysis for Elastic. Recent moves put that US$50.09 share price into context, with a 30 day share price return of 15.68%, a year to date share price decline of 30.97%, and a 1 year total shareholder return that has fallen 46.43%. This suggests that recent momentum has not yet...
NYSE:CNNE
NYSE:CNNEDiversified Financial

Cannae Holdings (CNNE) Losses Of US$410.7 Million Reinforce Bearish Earnings Narratives

Cannae Holdings (CNNE) opened 2026 with Q1 revenue of US$96.2 million and a basic EPS loss of US$0.70, while the trailing twelve months show revenue of US$416.6 million and a basic EPS loss of US$7.84 as losses have widened over recent years. Over the past six reported quarters, revenue has shifted from US$109.9 million in Q4 2024 to US$96.2 million in Q1 2026, with quarterly basic EPS losses ranging between about US$0.59 and US$3.75. This keeps the focus firmly on how much of each dollar of...
NasdaqGM:SEPN
NasdaqGM:SEPNPharmaceuticals

Septerna (SEPN) Q1 Loss Narrows To US$8.6 Million Challenging Bearish Earnings Narratives

Q1 2026 earnings snapshot Septerna (SEPN) opened 2026 with Q1 revenue of US$26.5 million and a basic EPS loss of US$0.19, as net income excluding extra items came in at a loss of US$8.6 million, against a trailing twelve month loss of US$36.0 million on US$72.3 million of revenue. The company has seen quarterly revenue move from US$0.2 million in Q1 2025 to US$26.5 million in Q1 2026, while basic EPS has shifted from a loss of US$0.49 to a loss of US$0.19 over the same period. This frames a...
NYSE:BSX
NYSE:BSXMedical Equipment

Is Boston Scientific’s (BSX) ESOP Shelf Plan Quietly Reframing Its Long‑Term Capital Allocation Strategy?

Earlier this month, Boston Scientific Corporation filed a shelf registration to offer 10,000,000 shares of common stock, valued at about US$565.7 million, in connection with an employee stock ownership plan–related offering. Alongside this prospective capital-raising capacity, a series of director equity and deferred stock unit awards highlights ongoing emphasis on equity-based compensation and board alignment with shareholders. We’ll now explore how Boston Scientific’s new ESOP-linked shelf...
NYSE:SE
NYSE:SEMultiline Retail

Sea (SE) Is Up 13.7% After Broad-Based Q1 Beat And Record Shopee GMV Growth Has The Bull Case Changed?

In the first quarter of 2026, Sea Limited reported revenue of US$7.10 billion, up from US$4.84 billion a year earlier, with net income rising to US$427.94 million and both basic and diluted EPS improving slightly year on year. The results showed broad-based strength, with Shopee hitting record gross merchandise value and orders, Garena delivering its best quarter since 2021, and Sea adding millions of paying users while generating over US$1 billion in adjusted EBITDA and repurchasing...
NYSE:APAM
NYSE:APAMCapital Markets

Is It Time To Reassess Artisan Partners Asset Management (APAM) After Recent Share Price Weakness

If you are wondering whether Artisan Partners Asset Management is offering genuine value at its current share price, this article walks through what the numbers are really saying. The stock last closed at US$36.94, with returns that slipped 1.7% over the past week, edged up 0.3% over the past month, and declined 10.8% year to date, while the 1 year return is down 6.8% and the 3 and 5 year returns stand at 47.0% and 10.2% respectively. Recent coverage around the company has focused on its...
NYSE:UP
NYSE:UPAirlines

Wheels Up Experience (UP) Quarterly Loss Improvement Challenges Bearish Earnings Narrative

Wheels Up Experience (UP) has just posted its latest quarterly scorecard, with Q4 2025 revenue of US$183.8 million and a basic EPS loss of US$0.80 that keeps profitability firmly in the red. Over the past year, revenue across reported quarters has ranged from US$177.5 million to US$189.6 million, while quarterly EPS losses have moved between US$0.80 and US$2.84, setting a clear backdrop of pressured margins that puts the focus squarely on how efficiently each dollar of sales is being...
NYSE:AR
NYSE:AROil and Gas

Assessing Antero Resources (AR) Valuation After Recent Share Price Weakness

Context for investors after recent price moves Antero Resources (AR) has seen its stock slide about 4% over the past month and about 7% over the past week, catching investors attention after a period of mixed recent returns. See our latest analysis for Antero Resources. Short term momentum has cooled for Antero Resources, with the stock down 7.16% over the past week and 4.12% over the past month. However, a 6.20% year to date share price return and a 64.99% three year total shareholder return...
NasdaqGS:DSP
NasdaqGS:DSPSoftware

Viant Technology (DSP) EPS Loss Revives Bearish Margin Concerns Despite Growth Narratives

Viant Technology (DSP) has put fresh Q1 2026 numbers on the table, reporting revenue of US$88.5 million and a small EPS loss of US$0.03, against a trailing twelve month EPS of US$0.54 that reflects a very large 328.8% year over year earnings increase and 41% per year growth over the past five years. Over the past year, revenue has been forecast at 13.4% annual growth while earnings are projected at 36.1% per year, setting up a results picture where improving net margins and that large...
NYSE:AGL
NYSE:AGLHealthcare

Why agilon health (AGL) Is Up 160.1% After Profit Jumps On Better Medical Margins And Guidance

In the first quarter ended March 31, 2026, agilon health reported revenue of US$1.42 billion, net income of US$48.92 million, and basic earnings per share from continuing operations of US$1.80, all compared with the same period a year earlier. Despite lower revenue year-on-year, agilon health’s sharp improvement in profitability and higher earnings per share coincided with raised 2026 sales guidance driven by better medical margins. With agilon health posting stronger profitability despite...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Insmed (INSM) Is Down 16.8% After Reaffirming 2026 BRINSUPRI and ARIKAYCE Revenue Guidance

Insmed Incorporated recently reported first-quarter 2026 results showing a narrower net loss of US$163.56 million and reiterated 2026 revenue guidance for BRINSUPRI of at least US$1 billion and ARIKAYCE of US$450 million to US$470 million. The company is also set to showcase six presentations from its respiratory portfolio at ATS 2026, highlighting both new clinical data and its role in addressing underdiagnosis of bronchiectasis through an independently run quality improvement...
NYSE:TPR
NYSE:TPRLuxury

A Look At Tapestry (TPR) Valuation After Recent Share Price Weakness

Event context and recent price performance Tapestry (TPR) has drawn attention after recent trading saw the stock at a last close of US$131.73, with the price down about 12% over the past month and roughly 15% over the past 3 months. See our latest analysis for Tapestry. While the recent 1 month share price return is down 12.36% and the 3 month share price return is down 14.83%, the 1 year total shareholder return of 59.85% and 5 year total shareholder return of 222.90% show that longer...
NasdaqGS:WBTN
NasdaqGS:WBTNInteractive Media and Services

Webtoon Entertainment (WBTN) Q1 Loss Eases Sharply Challenging Bearish Profitability Narratives

WEBTOON Entertainment (WBTN) opened 2026 with Q1 revenue of US$320.9 million and a reported net loss of US$9.5 million, which translated into EPS of US$0.07 loss, alongside trailing twelve month revenue of about US$1.4 billion and a trailing EPS loss of roughly US$2.54. Over recent quarters the company has seen revenue range between US$325.7 million and US$378.0 million while quarterly EPS losses moved between roughly US$0.03 and US$2.36. This sets the backdrop for today’s US$12.16 share...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Q1 Loss Deepens And Tests High‑Growth Bullish Narratives

AST SpaceMobile (ASTS) opened Q1 2026 with total revenue of US$14.7 million and a basic EPS loss of US$0.66, alongside a net income loss of US$191.0 million. This sets a clear tone for what remains a scale up story rather than a profitability one. The company reported an increase in revenue from US$0.7 million in Q1 2025 to US$14.7 million in Q1 2026, while quarterly basic EPS moved from a loss of US$0.20 to a loss of US$0.66. This leaves investors focused on how quickly future top line...
NYSE:UAA
NYSE:UAALuxury

Under Armour (UAA) Trailing Losses Above US$500m Challenge Bullish Margin Rebuild Narrative

Under Armour (UAA) has reported a challenging set of FY 2026 numbers, with Q3 revenue at US$1.3 billion and a basic EPS loss of US$1.01. Trailing 12 month figures show revenue of US$5.0 billion and a basic EPS loss of US$1.22, alongside a net loss of US$519.7 million. Over recent quarters, revenue has moved between US$1.1 billion and US$1.4 billion, while EPS shifted from a profit of US$0.39 in FY 2025 Q2 to successive quarterly losses through FY 2026. This has created a results season in...
NYSE:PRKS
NYSE:PRKSHospitality

United Parks And Resorts (PRKS) Q1 Loss Tests Bullish Margin Improvement Narrative

United Parks & Resorts (PRKS) opened Q1 2026 with total revenue of US$278.3 million and a reported loss of US$34.1 million, translating to basic EPS of US$0.69 in the red as the seasonally softer quarter reset the earnings run rate investors saw through 2025. Over recent quarters the company has seen revenue move between US$286.9 million in Q1 2025 and a peak of US$511.9 million in Q3 2025, while basic EPS has ranged from a loss of US$0.29 in Q1 2025 to a high of US$1.62 in Q3 2025. This...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Harrow (HROW) Q1 Loss Of US$27.6 Million Rekindles Profitability Concerns

Harrow (HROW) Kicks Off 2026 With Mixed Top Line and a Return to Losses Harrow (HROW) opened 2026 with Q1 revenue of US$44.2 million and a basic EPS loss of US$0.74, while trailing twelve month revenue stood at US$268.7 million and trailing EPS was a loss of US$0.40. The company has seen quarterly revenue move from US$47.8 million in Q1 2025 to US$89.1 million in Q4 2025 before landing at US$44.2 million in Q1 2026. Over the same period, EPS swung from a loss of US$0.50 in Q1 2025 to a profit...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Valuation Check After Strong Revenue Growth And Narrowing Quarterly Loss

Legend Biotech’s Earnings Spark Fresh Interest in the Stock Legend Biotech (LEGN) recently released first quarter 2026 results, reporting revenue of US$305.1 million and a net loss of US$54.3 million. This compares with revenue of US$195 million and a net loss of US$101 million a year earlier. See our latest analysis for Legend Biotech. Legend Biotech’s 1 day share price return of 10.48% came alongside the earnings release, while the 30 day share price return of 55.62% suggests momentum has...
NYSE:FIS
NYSE:FISDiversified Financial

Fidelity National Information Services CommBank Win Highlights SaaS Growth Potential

Fidelity National Information Services (NYSE:FIS) has secured a major contract with Commonwealth Bank of Australia for its cloud-native FIS Data Integrity Manager reconciliation platform. The deal sits alongside recent product and client updates, including work with M1 and the rollout of the Lyriq platform and Project Keystone. For a company built around payment processing, core banking systems, and financial software, NYSE:FIS is leaning further into cloud-native, enterprise SaaS tools...
NYSE:UNP
NYSE:UNPTransportation

Is Union Pacific (UNP) Pricing Look Attractive After Recent Rail Infrastructure Focus?

Wondering if Union Pacific at around US$265.60 is offering you fair value or a potential mispricing opportunity? This article walks through the key signals that matter for long term investors. The stock has returned 0.6% over the past week, 6.0% over the last month, 14.5% year to date and 19.1% over the past year, which gives useful context before weighing what that price might imply about future risk and reward. Recent interest around Union Pacific has been supported by ongoing attention on...
NasdaqCM:ESOA
NasdaqCM:ESOAEnergy Services

Energy Services Of America (ESOA) Margin Compression Tests Bullish Growth Narratives In Q2 2026

Energy Services of America (ESOA) just posted Q2 2026 results with revenue of US$93.2 million and basic EPS of US$0.01, setting a more muted tone after a stronger run in prior quarters. The company has seen quarterly revenue move from US$76.7 million in Q2 2025 to US$93.2 million in Q2 2026, while basic EPS has swung from a Q2 2025 loss of US$0.41 to a slim profit of US$0.01. This puts the focus squarely on how consistently it can rebuild margins from here. See our full analysis for Energy...